Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07505485

Artificial Intelligence-Based Assessment of Endosseous Lesions

Artificial Intelligence-Based Assessment of Endosseous Lesions: A Prospective Clinical Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University of Bari Aldo Moro · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Despite these advances, CBCT interpretation remains largely qualitative and dependent on the clinician's experience. Conventional evaluation is based on two-dimensional slices and linear measurements, which may underestimate lesion complexity and spatial distribution. Recent developments in Artificial Intelligence in Medicine have introduced automated image segmentation tools capable of identifying lesion boundaries and calculating volumetric data. These technologies allow a transition from subjective assessment to objective, reproducible quantification. The potential clinical advantages include: * Objective measurement of lesion size (volume in mm³) * Improved surgical planning * Enhanced prediction of anatomical involvement * Reduction of diagnostic errors * Standardization of follow-up and outcome assessment Therefore, the aim of the present study was to evaluate the clinical impact of AI-based segmentation and volumetric analysis of endosseous lesions compared to conventional CBCT interpretation.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAI assisted EvaluationCBCT scans were processed using AI-based software capable of: * Automated segmentation of the lesion * 3D reconstruction * Volumetric calculation

Timeline

Start date
2026-04-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2026-04-01
Last updated
2026-04-15

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT07505485. Inclusion in this directory is not an endorsement.